Russell Clayton Larimar Therapeutics, Inc. (LRMR) insider trading activity

LRMR Quotes by TradingView

Russell Clayton is Chief Medical Officer of Larimar Therapeutics, Inc.. Currently has a direct ownership of 45,806 shares of LRMR, which is worth approximately $156,656. The most recent transaction as insider was on Jan 22, 2025, when has been sold 23,306 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.8K
103.58% 3M change
103.58% 12M change
Total Value Held $156,656

Russell Clayton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 22 2025
BUY
Grant, award, or other acquisition
-
23,306 Added 33.72%
45,806 Common Stock
Jan 17 2024
BUY
Grant, award, or other acquisition
-
22,500 Added 50.0%
22,500 Common Stock
RC

Russell Clayton

Chief Medical Officer
Bala Cynwyd, PA

Track Institutional and Insider Activities on LRMR

Follow Larimar Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LRMR shares.

Notify only if

Insider Trading

Get notified when an Larimar Therapeutics, Inc. insider buys or sells LRMR shares.

Notify only if

News

Receive news related to Larimar Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LRMR